NGL Fine-Chem Ltd. | Balance Sheet

Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
Cash & Short Term Investments
11
39
52
70
102
Total Accounts Receivable
240
261
327
340
277
Inventories
85
121
100
118
168
Other Current Assets
18
19
19
36
15
Total Current Assets
355
440
498
564
561
Net Property, Plant & Equipment
187
183
256
426
594
Total Investments and Advances
3
3
-
-
131
Intangible Assets
2
3
2
2
2
Other Assets
12
36
19
21
4
Total Assets
558
665
775
1,012
1,293
ST Debt & Current Portion LT Debt
133
116
141
134
113
Accounts Payable
116
171
137
145
235
Income Tax Payable
-
2
8
14
2
Other Current Liabilities
15
14
26
39
56
Total Current Liabilities
266
310
318
319
404
Long-Term Debt
34
16
3
95
124
Provision for Risks & Charges
-
-
-
-
15
Deferred Taxes
13
12
12
14
28
Other Liabilities
-
-
-
-
1
Total Liabilities
313
337
333
427
572
Common Equity (Total)
245
328
442
585
720
Total Shareholders' Equity
245
328
442
585
720
Total Equity
245
328
442
585
720
Liabilities & Shareholders' Equity
558
665
775
1,012
1,293

About NGL Fine-Chem

View Profile
Address
301, East Square
Mumbai Maharashtra 400057
India
Employees -
Website http://www.nglfinechem.com
Updated 09/14/2018
NGL Fine-Chem Ltd. manufactures pharmaceuticals and intermediates for usage in veterinary and human health. Its products include API animal and human health, intermediates, and finished dosage form. The company was founded on December 18, 1981 and is headquartered in Mumbai, India.